Back to 
MACKENZIE FINANCIAL CORP
MACKENZIE FINANCIAL CORP
ADPT
Showing 0 of 2 quarters
Position history for MACKENZIE FINANCIAL CORP's holdings in ADAPTIVE BIOTECHNOLOGIES
No. Mackenzie Financial exited its ADPT (Adaptive Biotechnologies) position in Q3 2022. Its Q2 2022 13F listed 10,230 shares worth $83,000. Mackenzie Financial first reported ADPT in Q2 2022 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.